Dimethylformamide dimethyl acetal → HCID 13375846, compound
Reaction equation
[NH2:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[CH2:4][CH2:3]1.CO[CH:17](OC)[N:18]([CH3:20])[CH3:19]>>[CH3:17][N:18]([CH3:20])[CH:19]=[N:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[CH2:4][CH2:3]1Participants
3
Procedure
The starting 4-amino-1-benzylpiperidine from Part B above (15.0 g, 78.8 mmol) is treated with dimethylformamide dimethylacetal (18.78 g, 157.6 mmol) and refluxed for 2 hours. The solution is permitted to cool overnight, then concentrated in vacuo to the product (15.5 g of oil, 83.2% yield), which solidifies on standing. A small portion crystallizes from hexane to afford colorless needles with a melting point of 61°-65° C.: NMR (CDCl3 δ) 7.28, 3.49, 2.80, and 1.75-3.0; mass spectral molecular ion peak at m/e 245, with abundant fragment ions at m/e 200, 173, 172, 154, and 91.
Workup
- temperaturerefluxed for 2 hours
- temperatureto cool overnight
- concentrationconcentrated in vacuo to the product (15.5 g of oil, 83.2% yield), which
- customA small portion crystallizes from hexane
- customto afford colorless needles with a melting point of 61°-65° C.
Sources & evidence
- ORD record
- ord-edfa9d44bc0442849eaaf302b658b2a6
- Source dataset
- uspto-grants-1984_11
- Patent number
- US04481360
Reaction notes
Loading…